UBS Group’s Skylight Health Group Inc Common Shares SLHG Stock Holding History

UBS Group’s Portfolio SLHG Stock Details SLHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,215	Closed	-$7K	–	11727
2022 Q2	$7K	Buy	14,215 +5,582	+65%	+$4.36K	﹤0.01%	8622
2022 Q1	$9K	Buy	8,633 +6,522	+309%	+$6.58K	﹤0.01%	8631
2021 Q4	$3K	Buy	2,111 +2,082	+7,179%	+$4.41K	﹤0.01%	9760
2021 Q3	$0	Sell	29 -1,823	-98%	-$5.95K	﹤0.01%	10542
2021 Q2	$8K	Buy	+1,852	New	+$8.33K	﹤0.01%	8285

UBS Group's SLHG Position: Q3 2022 in Review

UBS Group sold out of Skylight Health Group Inc Common Shares (SLHG) in Q3 2022, closing a stake of 14,215 shares — an estimated $7K sold.

UBS Group first reported a position in SLHG in Q2 2021 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 0 funds tracked by Wall St. Rank hold SLHG as of Q3 2022.

UBS Group reported no remaining Skylight Health Group Inc Common Shares position as of Q3 2022 after selling out during the quarter.
UBS Group sold 14,215 Skylight Health Group Inc Common Shares shares in Q3 2022, an estimated $7K.
UBS Group first reported a position in Skylight Health Group Inc Common Shares in Q2 2021 and held it in 5 quarters.
UBS Group's Skylight Health Group Inc Common Shares position peaked at $9K in Q1 2022.
0 funds tracked by Wall St. Rank held Skylight Health Group Inc Common Shares as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.